|School of Medicine successfully hosts the IEID Biology and Life Science Technology and Industry Meeting|
The 2017 International Conference on Innovative and Emerging Industries Development Meeting (IEID), co-hosted by the Chinese Academy of Engineering, the Shanghai Municipal People‘s Government, the Ministry of Industry and Information Technology and the National Development and Reform Commission, was recently held at the Shanghai International Convention Center One of the main activities, which was also the main part of the China International Industry Fair.On November 8,as an important part of the conference, the Biology and Life Science Technology and Industry Branch Meeting hosted by Shanghai JiaoTong University School of Medicine(SJTU-SM) was successfully held, which was chaired by Professor Cao Yilin, director of the National Organization for Engineering, while Fan Xianqun,Party Committee Secretary ofSJTU-SM gave a welcome speech.
With the theme of “Regenerative Medicine and 3D Printing”, attended the conference were except Professor Dai Kerongof the Ninth People’s Hospital Affiliated to SJTU-SM andalso an academician of the Chinese Academy of Engineering,Nicholas A. Peppas, the professor of the University of Texas at Austin, the National Academy of Engineering of the United States and president of the International Federation of Biomaterials, Aleksandr Ovsianikov, director of the Institute of Materials Science and Technology at the Vienna Polytechnic University, Xu Tao, professor of biological manufacturing at Tsinghua University, James Yoo, associate professor and chief scientist at Wake Forest Regenerative Medicine, David Williams, chairman of TERMIS, Jinyan,Director of Tissue Engineering Research Center of Fourth Military Medical University, Professor Gordon Wallace of Australian State Key Laboratory of Electrochemical Materials,Professor Sun Wei of Drexel University, Lars Neumann, Managerof Industry and Applications and Industrial Additives Manufacturing of General Electric, andProfessor Gerald Thomas Grant, Interim Chair of the Department of Oral Health and Rehabilitation of University of Louisville School of Dentistry.They made wonderful speeches on such topics asregenerative medicine, stem cell therapy and 3D printing technology to discuss ways of basic research to translational research, clinical applications and product development transformation.
Tissue engineering is an important part of regenerative medicine and is also one of the important tissue regeneration technologies. After more than 20 years of development, tissue engineering has been transformed from basic research to translational research, clinical application and product research. 3D printing, also known as additive manufacturing technology, is a revolutionary manufacturing technology that subverts traditional production methods, which is also known as another great invention following the steam engine, computer and internet. At present, the application of 3D printing technology in the medical field is developing rapidly, becoming one of the key technologies leading the development of modern clinical medicine. The use of 3D printing technology can quickly achieve a variety of personalized medical models, auxiliary equipment, implants and other product, which is of great help to achieve clinical individualized and accurate treatment.
During the session, Prof. Dai Kerong introduced the research on cartilage and bone regeneration based on 3D printing, tissue engineering and bioreactor technology. He believed thatthe research and practice of regenerative medicine combined with 3D printing and biotechnology was progressively promoted or would be prized the core of the future medical technology. He said that tissue engineering-based regenerative medicine had been the hot frontier research in the field of medicine since the beginning of this century. There were three elements of traditional tissue engineering: scaffolds, cells (attached to scaffold amplification, mainly pluripotent stem cells) and growth factorsso as to “regenerate”such tissues and even organs needed by humans as new muscles, nerves and bones. With the invention and application of 3D printing, its combination with tissue engineering had given birth to new development prospects. In 2004, some foreign experts proposed “tissue-engineered joints.” It should be known that the earliest 3D printing was used to make stents, custom stents, for example, according to patients‘ needs, “print” a custom joint. This was a lifeless stent, but when researchers put cells with growth factors into a 3D printer, it was not just printing a stent, but printing out a living stent, which was vividly called a 3D creature print. At present, these ideas have appeared in the laboratory stage. Researchers in the laboratory with 3D had printed such cartilage, “planted” it on the backin the nude mice, making the nude mice as a living bioreactor, then cultured for 10 weeks, finally cartilage alive. In Shanghai Ninth People’s Hospital, cooperating with the Shanghai JiaoTong University School of Materials for many years, their research almost simultaneously followed with foreign countries. In addition to itsextraordinary medical experts of Microsurgery technology, clinical practice had greatly improved the success rate of 3D printing and tissue engineering.